The Targeted Pulse: New Trial Evaluating Iadademstat/Azacitidine in MDS and Positive Trends in HNSCC
Forward steps are being made in HNSCC, and the first patient with MDS has been treated with iadademstat/azacitidine.
Dr. Sara M. Tolaney discusses breast practices associated with CDK4/6 inhibitors for the treatment of breast cancer. At the 42nd Annual Miami Breast Cancer Conference, Dr. Sara M. Tolaney sat down for ...
Medscape Medical News, February 28, 2025 How Do ADCs Affect Safety and QOL in Breast Cancer? Antibody-drug conjugates show distinct safety profiles and improve quality of life in metastatic breast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback